These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3371 related items for PubMed ID: 15026990

  • 1. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 2. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 3. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 4. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 01; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 5. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Jun 01; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 6. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K.
    J Gene Med; 2009 May 01; 11(5):373-81. PubMed ID: 19274675
    [Abstract] [Full Text] [Related]

  • 7. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 01; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May 01; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 9. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A, Ben-Kasus T, Mahajna JA, Danon A, Rimon G, Agbaria R.
    Cancer Gene Ther; 2004 Dec 01; 11(12):830-40. PubMed ID: 15359292
    [Abstract] [Full Text] [Related]

  • 10. Adeno-retroviral chimeric viruses as in vivo transducing agents.
    Caplen NJ, Higginbotham JN, Scheel JR, Vahanian N, Yoshida Y, Hamada H, Blaese RM, Ramsey WJ.
    Gene Ther; 1999 Mar 01; 6(3):454-9. PubMed ID: 10435096
    [Abstract] [Full Text] [Related]

  • 11. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB, Nicholas T, Kruse CA.
    Cancer Gene Ther; 2002 Jan 01; 9(1):87-95. PubMed ID: 11916247
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
    Yamaguchi T, Okada T, Takeuchi K, Tonda T, Ohtaki M, Shinoda S, Masuzawa T, Ozawa K, Inaba T.
    Gene Ther; 2003 Mar 01; 10(5):375-85. PubMed ID: 12601392
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 01; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 14. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM, Turunen M, Tyynelä K, Loimas S, Vainio P, Vanninen R, Vapalahti M, Bjerkvig R, Jänne J, Ylä-Herttuala S.
    Cancer Gene Ther; 2000 Mar 01; 7(3):413-21. PubMed ID: 10766347
    [Abstract] [Full Text] [Related]

  • 15. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 01; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 17. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E, Kawano K, Hattori Y, Fukushima M, Hayashi K, Maitani Y.
    J Control Release; 2007 Jul 16; 120(1-2):104-10. PubMed ID: 17509714
    [Abstract] [Full Text] [Related]

  • 18. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O, Síma P, Kunke D.
    Int J Oncol; 2003 Mar 16; 22(3):569-77. PubMed ID: 12579310
    [Abstract] [Full Text] [Related]

  • 19. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H, Huang ZH, Li Q, Yang LC, Yu JL, Li Z.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun 16; 28(6):907-10. PubMed ID: 18583225
    [Abstract] [Full Text] [Related]

  • 20. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
    Lyons RM, Forry-Schaudies S, Otto E, Wey C, Patil-Koota V, Kaloss M, McGarrity GJ, Chiang YL.
    Cancer Gene Ther; 1995 Dec 16; 2(4):273-80. PubMed ID: 8548581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 169.